Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue-specific methylation differences in a fragile X premutation carrier.

F Tassone1, J Longshore, J Zunich

  • 1Kimball Genetics Inc., Denver, CO, USA. Flora.Tassone@uchsc.edu

Clinical Genetics
|July 28, 1999
PubMed
Summary

Methylation patterns of the FMR1 premutation vary between blood and skin cells. This inter-tissue heterogeneity in methylation did not impact Fragile X mental retardation protein (FMRP) expression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diabetic retinopathy screening telemedicine-based compared with standard of care : an economic analysis in a pilot experience of Italian healthcare.

Acta diabetologica·2025
Same author

Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Evaluation of How Integrative Oncology Services Are Valued between Hematology/Oncology Patients and Hematologists/Oncologists at a Tertiary Care Center.

Evidence-based complementary and alternative medicine : eCAM·2018
Same author

Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2017
Same author

Metformin as targeted treatment in fragile X syndrome.

Clinical genetics·2017

Area of Science:

  • Genetics
  • Molecular Biology
  • Neuroscience

Background:

  • The Fragile X mental retardation 1 (FMR1) gene is associated with Fragile X syndrome.
  • FMR1 premutations can exhibit variable methylation patterns.
  • Understanding tissue-specific methylation is crucial for FMR1-related disorders.

Purpose of the Study:

  • To investigate inter-tissue heterogeneity of FMR1 premutation methylation.
  • To explore potential clinical implications of methylation differences.
  • To assess Fragile X mental retardation protein (FMRP) expression in different tissues.

Main Methods:

  • Analysis of FMR1 premutation size and methylation in leukocytes and fibroblasts.
  • Cell culture of fibroblast cells.
  • Immunocytochemical analysis of FMRP expression in fibroblasts and blood smears.

Related Experiment Videos

Main Results:

  • FMR1 premutation size was consistent between leukocytes and fibroblasts.
  • Fibroblast cells showed complete unmethylation of the premutation.
  • A small percentage of lymphocytes exhibited premutation methylation.
  • FMRP expression levels were normal in both cultured fibroblasts and blood smears.

Conclusions:

  • Tissue-specific methylation patterns of FMR1 premutations can exist.
  • This methylation heterogeneity did not correlate with altered FMRP expression in the studied tissues.
  • Further research is needed to understand the clinical significance of inter-tissue FMR1 methylation differences.